What's breaking now, across thousands of outlets.
Explore how integrated scenario modeling helps pharma leaders navigate pricing uncertainty and the complexity of global launches.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
[Leadership] Thirty-two people in Senegal have been charged with "unnatural acts" and the wilful transmission of HIV and referred to trial.
[Daily Maverick] The arrival of drugs such as Ozempic and Mounjaro has transformed weight loss. But what happens when people stop taking them?
Healthcare recorded 28 PE/VC deals in Q3 2026, up from 19 in the previous quarter, with September alone accounting for 11 deals.
GLP-1 (glucagon-like peptide-1 receptor agonists) medications, currently popular for weight loss, may help prevent type 2 diabetes and lower the risk of heart attack and stroke more than the standard…
An eight-month program providing medically tailored meals improved diet quality and access to healthy food for adults with type 2 diabetes and high blood pressure.
Caffeinated energy drinks and stimulant supplements appeared disproportionately more often in FDA reports of serious cardiovascular events, including cardiac arrest and heart attacks, especially among…
